<PAGE> 1
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
The Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): January 16, 2001
----------------
RENAL CARE GROUP, INC.
--------------------------------------------------------------------------------
(Exact name of registrant as specified in its charter)
Delaware 0-27640 62-1622383
(State or other (Commission (IRS Employer
jurisdiction of File Number) Identification No.)
incorporation)
2100 West End Avenue, Suite 800, Nashville, Tennessee 37203
--------------------------------------------------------------------------------
(Address, including zip code, of principal executive offices)
(615) 345-5500
--------------------------------------------------------------------------------
(Registrant's telephone number, including area code)
1
<PAGE> 2
Item 7. Financial Statements and Exhibits.
(c) Exhibits.
99.1 Slide presentation to be used at analyst and
shareholder meetings between January 16, 2001 and
February 9, 2001.
Item 9. Regulation FD Disclosure.
Beginning during the week of January 15, 2001 and continuing through
February 9, 2001, one or more officers of Registrant will make slide
presentations to a number of shareholders of Registrant, as well as potential
investors and investment analysts. The slide presentation contains, among other
things, forward-looking information about Registrant and its business. The
slides that the Registrant will use in these presentations are attached to this
Current Report on Form 8-K as Exhibit 99.1.
Certain statements in the slide presentation constitute
"forward-looking statements" within the meaning of the Private Securities
Litigation Reform Act of 1995. These forward-looking statements reflect
management's expectations and are based on currently available information.
These forward-looking statements involve known and unknown risks, uncertainties
and other factors that may cause actual results, performance or achievements of
Renal Care Group to differ materially from those expressed or implied by the
forward-looking statements, including risks related to: the integration of
acquired businesses; compliance with health care and other applicable laws;
changes in the Medicare and Medicaid programs; payment reductions by private
insurers, hospitals or managed care organizations; reductions in reimbursement
for Epogen; increases in the price of Epogen or shortages of Epogen;
competition; inability to identify and make acquisitions; and changes in the
health care delivery, financing or reimbursement systems. These and other
factors affecting the company are discussed in more detail in Renal Care Group's
reports filed with the Securities and Exchange Commission, including without
limitation, Renal Care Group's annual report on Form 10-K for the year ended
December 31, 1999 and Renal Care Group's quarterly report on Form 10-Q for the
quarter ended September 30, 2000.
Renal Care Group does not have, and expressly disclaims, any
obligation to release publicly any updates or changes in Renal Care Group's
expectations or any changes in events, conditions or circumstances on which any
forward-looking statement is based.
The information in this current report on Form 8-K is furnished
pursuant to Item 9 and shall not be deemed to be "filed" for the purposes of
Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise
subject to the liabilities of that section. This current report on Form 8-K will
not be deemed an admission as to the materiality of any information in the
report that is required to be disclosed solely by Regulation FD. The Registrant
undertakes no duty to update the information in this current report on Form 8-K
and warns readers that the information included in this current report on Form
8-K will become stale after February 9, 2001.
2
<PAGE> 3
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
RENAL CARE GROUP, INC.
By: /s/ R. Dirk Allison
----------------------------------------
Name: R. Dirk Allison
--------------------------------------
Title: Chief Financial Officer
-------------------------------------
Date: January 16, 2001
3
<PAGE> 4
INDEX TO EXHIBITS
Exhibit
Number Description of Exhibits
------ -----------------------
99.1 Slide presentation to be used at analyst and shareholder
meetings between January 16, 2001 and February 9, 2001
4
